LUHMES Cells: Phenotype Refinement and Development of an MPP(+)-Based Test System for Screening Antiparkinsonian Drugs

The low effectiveness of symptomatic pharmacotherapy for Parkinson’s disease (PD), which compensates for dopamine (DA) deficiency under degeneration of nigrostriatal dopaminergic (DAergic) neurons, could apparently be improved with neuroprotective therapy, which slows down neurodegeneration and PD p...

Descripción completa

Detalles Bibliográficos
Autores principales: Beliakov, Sergei V., Blokhin, Victor, Surkov, Sergey A., Ugrumov, Michael V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821222/
https://www.ncbi.nlm.nih.gov/pubmed/36614176
http://dx.doi.org/10.3390/ijms24010733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821222/
https://www.ncbi.nlm.nih.gov/pubmed/36614176
http://dx.doi.org/10.3390/ijms24010733

Ejemplares similares